Research Indicates IP-6 May Prevent Type II Diabetes

Research Indicates IP-6 May Prevent Type II Diabetes

MELBOURNE, Fla.--IP6 International Inc. announcedat Expo West, held in Anaheim, Calif., March 6 to 9, that phosphorylatedinositol compounds--particularly inositol hexakisphosphate (IP-6)--are nowthought to be key players in preventing Type II diabetes. According to a studyout of The Rolf Luft Center for Diabetes Research in Stockholm, Sweden,phosphorylated inositol compounds, including IP-6, are integral for insulinsecretion through their regulation of pancreatic beta cell function. "IP-6appears to be involved in the initial steps that lead to insulin secretion thatin turn starts a cascade reaction, principally through the activity ofphosphatidylinositol 3-kindase, ultimately activating a key gene that itselfeither terminates or enhances subsequent insulin secretion events,"according to IP6 International (www.ip-6.com).